Nephrocare Health IPO allotment likely today: GMP, how to check allotment status online
Nephrocare Health IPO allotment is likely today as strong demand, healthy GMP and December 17 listing keep investors focused on allotment status.
Investors await Nephrocare Health IPO allotment and listing updates.
The allotment of Nephrocare Health Services IPO is expected to be finalised today, December 15, following strong investor demand during the subscription period. Through the NSE, BSE, or the registrar’s website, Kfin Technologies, one can verify the status of their allotment online.
The public offering, which was available for application from December 10 till December 12, got an enormous response as it was overall subscribed 14.08 times. After the allotment process is likely to be completed today, the winners of the bidding will get the shares credited to the demat accounts, and the unsuccessful applicants will have their refunds processed on December 16. The company is scheduled to make its stock market debut on December 17 on both NSE and BSE.
How to check Nephrocare Health IPO allotment status
Via BSE or NSE:
Investors can visit the BSE IPO allotment page or the NSE IPO bid verification page, select the equity issue, choose Nephrocare Health Services from the dropdown, and enter their application number and PAN to view the allotment status.
Via Kfin Technologies:
Applicants can also log on to the registrar’s website, select Nephrocare Health Services, enter their PAN, demat details, or application number, and submit the request to check their allotment status.
Nephrocare Health IPO GMP today
In the grey market, Nephrocare Health shares are trading at a premium of around ₹34.5 per share. Based on this GMP, the stock is estimated to list at approximately ₹494.50, indicating a potential upside of about 7.5% over the IPO price.
Subscription details
The IPO attracted bids for 18.69 crore shares against an offer of 1.32 crore shares. The QIB segment was subscribed 26.82 times, the NII portion 24.77 times, retail investors 2.36 times, and the employee quota 2.81 times.
IPO details and company overview
The ₹871.05 crore issue comprised a fresh issue worth ₹353.40 crore and an offer for sale amounting to ₹517.64 crore. Proceeds from the fresh issue will be used to expand dialysis clinics, repay borrowings, and support general corporate purposes. The IPO had a lot size of 32 shares, requiring a minimum retail investment of ₹14,720.
Founded in 2010, Nephrocare Health Services is a leading dialysis care provider with a wide network across India and overseas markets. As of September 2025, the company operated 519 clinics across India, the Philippines, Uzbekistan, and Nepal, with a strong focus on tier II and tier III cities, catering to underserved patient populations.
